• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Weekly Roundup: November 19-24


ICYMI, this week we had articles about KT-474 efficacy in atopic dermatitis and hidradenitis suppurativa, endoscopic thoracic sympathectomy surgery for hyperhidrosis, and new data on rademikibart for atopic dermatitis.

Exploring Dx Issues in SOC Atopic Dermatitis at ACAAI

Ama Alexis, MD, shared the importance of recognizing diverse presentations of atopic dermatitis at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

The Journal Digest: November 20

This week’s collection of the latest dermatologic studies covers the relationship between melanoma pigmentation and inflammatory cytokines, the negative use of topical nystatin for tinea infections, the association between psoriasis and schizophrenia, and the association between pediatric atopic dermatitis and cardiovascular risk factors.

KT-474 Demonstrates Efficacy and Promise in Atopic Dermatitis and Hidradenitis Suppurativa Study

Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.

Navigating Nutrition Support For Patients With Atopic Dermatitis

Atoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.

A Shift in Adjuvant Therapy: FDA Approves Nivolumab for Completely Resected Stage IIB/C Melanoma

Immunotherapies, including PD-1 checkpoint inhibitors such as nivolumab, have improved the treatment options for patients with advanced melanoma.

Understanding Topical Growth Factors and Skin Rejuvenation

The newest source of growth factors is from donor tissue.

The AD Tx Revolution at ACAAI

Andrew F. Alexis, MD, MPH, shared insights into using JAK inhibitors as part of the treatment revolution in atopic dermatitis at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Frontline Forum Part 2: Topical Therapy for Corticosteroid-Responsive Dermatoses

Experts discuss enhancing patient outcomes, topical formulations and epidermal barrier dysfunction, and more.

Key Considerations for Optimal Atopic Dermatitis Care Across All Ages

From the November cover: Raj Chovatiya, MD, PhD, and Lawrence Eichenfield, MD, shared their insights and key treatment pearls into atopic dermatitis management for adults and children.

Endoscopic Thoracic Sympathectomy Surgery for Hyperhidrosis: Patient and Physician Perspectives

Patient Cole Villaflor, his mother, and Michael Levy, MD, PhD, provide insights into Cole’s hyperhidrosis diagnosis and subsequent endoscopic thoracic sympathectomy surgery.

Abrocitinib Efficacious in Atopic Dermatitis Regardless of Allergic Comorbidities

Patients with AD and a comorbid allergic condition achieved the same efficacy endpoints as patients without allergic conditions in a study.

Treatment With Rademikibart Led to Clinically Meaningful Responses in Patients With Atopic Dermatitis

Connect Biopharma announced positive long-term data from its China pivotal trial.

CVS Removes Biosimilars From Drug List

One notable change: CVS Caremark has removed the Humira biosimilar Amjevita and now prefers Hyrimoz and an unbranded biosimilar.

Investigating Links Between Cancer and Psoriasis Management

Because of the chronic inflammatory state of psoriasis and the immunosuppression produced by some systemic medications, patients with psoriasis may have an increased risk of lymphoma and nonmelanoma skin cancer.

2023 Innovations Garnering Gratitude

Members of Dermatology Times’ Editorial Advisory Board share their perspectives on the most meaningful innovations of the year this Thanksgiving Day.

POLL: What Percent of Those With Hyperhidrosis Have Discussed Their Sweating With a Health Care Professional?

Click here to answer this week's poll for Hyperhidrosis Awareness Month.

Study Finds Disparities in Access to Patient Portals Despite a Rise in Use

The study found that white patients were offered access to patient portals more frequently than Black or Hispanic patients.

To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.